Adverse events30

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 30

Type	Event	Organ system	Group	Affected	At risk	Events
other	Headache	Nervous system disorders	Cohort 1: Participants Aged 9 to 17 Years	114	641	121
other	Headache	Nervous system disorders	Cohort 2: Participants Aged 18 to 49 Years	152	658	153
other	Myalgia	Musculoskeletal and connective tissue disorders	Cohort 1: Participants Aged 9 to 17 Years	119	641	119
other	Myalgia	Musculoskeletal and connective tissue disorders	Cohort 2: Participants Aged 18 to 49 Years	129	658	129
other	Chills	General disorders	Cohort 1: Participants Aged 9 to 17 Years	45	641	45
other	Chills	General disorders	Cohort 2: Participants Aged 18 to 49 Years	40	658	40
other	Injection Site Pain	General disorders	Cohort 1: Participants Aged 9 to 17 Years	212	641	212
other	Injection Site Pain	General disorders	Cohort 2: Participants Aged 18 to 49 Years	255	658	256
other	Malaise	General disorders	Cohort 1: Participants Aged 9 to 17 Years	100	641	100
other	Malaise	General disorders	Cohort 2: Participants Aged 18 to 49 Years	106	658	106
serious	Intentional Overdose	Injury, poisoning and procedural complications	Cohort 1: Participants Aged 9 to 17 Years	0	641	0
serious	Intentional Overdose	Injury, poisoning and procedural complications	Cohort 2: Participants Aged 18 to 49 Years	1	658	1
serious	Overdose	Injury, poisoning and procedural complications	Cohort 1: Participants Aged 9 to 17 Years	0	641	0
serious	Overdose	Injury, poisoning and procedural complications	Cohort 2: Participants Aged 18 to 49 Years	1	658	1
serious	Spinal Fracture	Injury, poisoning and procedural complications	Cohort 1: Participants Aged 9 to 17 Years	1	641	1
serious	Spinal Fracture	Injury, poisoning and procedural complications	Cohort 2: Participants Aged 18 to 49 Years	0	658	0
serious	Seizure	Nervous system disorders	Cohort 1: Participants Aged 9 to 17 Years	0	641	0
serious	Seizure	Nervous system disorders	Cohort 2: Participants Aged 18 to 49 Years	1	658	1
serious	Obstructive Pancreatitis	Gastrointestinal disorders	Cohort 1: Participants Aged 9 to 17 Years	0	641	0
serious	Obstructive Pancreatitis	Gastrointestinal disorders	Cohort 2: Participants Aged 18 to 49 Years	1	658	1

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT05513053/events

API reference For AI assistants

Adverse events30

Sources 3

Read this list from software.